AI assistant
Sending…
Terns Pharmaceuticals, Inc. — Director's Dealing 2024
Jun 15, 2024
32559_dirs_2024-06-14_ec67219a-6b06-4b07-8ee3-d1116f2b232d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Terns Pharmaceuticals, Inc. (TERN)
CIK: 0001831363
Period of Report: 2024-06-10
Reporting Person: Taylor Ann Elizabeth (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-06-10 | Stock Option (Right to Buy) | $6.99 | A | 32000.00 | Acquired | 2034-06-09 | Common Stock (32000.00) | Direct |
Footnotes
F1: The option will vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant.